JPMorgan Chase & Co. Issues Pessimistic Forecast for H.B. Fuller (NYSE:FUL) Stock Price

H.B. Fuller (NYSE:FUL) had its price target reduced by analysts at JPMorgan Chase & Co. from $60.00 to $50.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an “underweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price target points to a potential downside of 13.20% from the stock’s previous close.

FUL has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft decreased their target price on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating for the company in a research note on Wednesday, January 22nd. Vertical Research cut shares of H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. Citigroup dropped their target price on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Finally, Seaport Res Ptn cut shares of H.B. Fuller from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $70.00.

H.B. Fuller Trading Up 6.1 %

NYSE FUL opened at $57.61 on Friday. H.B. Fuller has a 52 week low of $52.59 and a 52 week high of $87.67. The firm has a 50 day moving average of $58.46 and a two-hundred day moving average of $68.92. The company has a quick ratio of 1.16, a current ratio of 1.81 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $3.12 billion, a PE ratio of 24.94, a price-to-earnings-growth ratio of 1.13 and a beta of 1.41.

H.B. Fuller (NYSE:FUL) last issued its earnings results on Wednesday, March 26th. The specialty chemicals company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.05. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The firm had revenue of $788.66 million during the quarter, compared to the consensus estimate of $769.55 million. During the same quarter in the previous year, the firm posted $0.67 earnings per share. The company’s revenue was down 2.7% compared to the same quarter last year. As a group, research analysts expect that H.B. Fuller will post 4.07 EPS for the current fiscal year.

Institutional Investors Weigh In On H.B. Fuller

Several hedge funds have recently made changes to their positions in FUL. Geode Capital Management LLC increased its position in H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after acquiring an additional 18,734 shares during the period. Lord Abbett & CO. LLC increased its holdings in shares of H.B. Fuller by 79.8% in the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after purchasing an additional 324,056 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of H.B. Fuller by 17.2% during the fourth quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock worth $37,448,000 after purchasing an additional 81,558 shares during the period. Kennedy Capital Management LLC grew its position in H.B. Fuller by 13.4% in the 4th quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company’s stock valued at $8,630,000 after buying an additional 15,100 shares during the last quarter. Finally, MetLife Investment Management LLC increased its stake in H.B. Fuller by 4.7% in the 4th quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company’s stock valued at $2,231,000 after buying an additional 1,472 shares during the period. Institutional investors and hedge funds own 95.93% of the company’s stock.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.